Broad tumor cell populations and immune cells

The term "Broad tumor cell populations and immune cells" does not describe a single molecular target but rather refers to the collective cellular components of the tumor microenvironment (TME). This ecosystem includes malignant cells and a diverse array of infiltrating immune cells, such as cytotoxic T lymphocytes, regulatory T cells, macrophages, and dendritic cells, which interact through a complex network of cytokines and surface receptors (National Cancer Institute, 2023). In modern oncology, therapeutic strategies often focus on modulating these broad populations to shift the environment from pro-tumorigenic to anti-tumorigenic, as seen with the use of immune checkpoint inhibitors or CAR-T cell therapies (Nature Reviews Cancer, 2021). Because this term encompasses a vast range of distinct proteins and pathways, it is considered a descriptive category of therapeutic scope rather than a specific, druggable receptor or enzyme. Understanding the spatial and functional heterogeneity of these populations is critical for predicting drug efficacy and overcoming mechanisms of resistance in cancer treatment.

Other names

Tumor microenvironmentTMECancer cell and immune cell populationsTumor-infiltrating immune cells

Not applicable as this refers to a heterogeneous population of cells rather than a specific molecular target.